INDUSTRY stalwart Carl Gibson (pictured), CEO of Complementary Medicines Australia (CMA), has announced his retirement.
"It is fair to say that this job has been my life for the last 10 incredible years, and we have achieved a lot together," Gibson said.
"But this has been at the detriment to my own health and I have neglected my family and friends.
"So as I prepare to retire I pledge to reintroduce myself to my family and friends.
"From the bottom of my heart this has been an incredible journey, and a true privilege."
Gibson said the CMA has campaigned, protected, and grown the industry.
"CMA has campaigned for appropriate regulation and we have the most progressive regulatory system in the world.
"It may not be perfect but it's the envy of the world.
"CMA protects the industry from critics and detractors by defending the right to use 1,200 traditional evidence claims, and has protected the industry from illegal imports with over 850,000 illegal products seized and destroyed and 13,000 unlawful sales listings of products removed from eCommerce sites," he said.
"CMA has grown the industry from $2b to over $6b in sales, by working to open new export markets and secure preferential trade tariffs.
"But the work isn't over, the CMA will continue to campaign for comp meds to be at the heart of a preventive health strategy, and the return of rebates for natural therapies," he added, with a new CEO to come on board by 13 Jun.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Apr 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Apr 23
